BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases
- 1 June 2016
- journal article
- Published by Elsevier in Human Pathology
- Vol. 52, 61-67
Abstract
No abstract availableKeywords
Funding Information
- Saudi Arabian Cultural Mission
This publication has 30 references indexed in Scilit:
- B-Raf mutation: A key player in molecular biology of cancerExperimental and Molecular Pathology, 2013
- Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of MelanomaThe Journal of Molecular Diagnostics, 2013
- Targeting the RAF–MEK–ERK pathway in cancer therapyCancer Letters, 2009
- Chapter 1 Ras Signaling and Therapies2009
- Spontaneous Regression of Langerhans Cell Histiocytosis in a Neonate With Multiple Bony LesionsJournal of Pediatric Hematology/Oncology, 2008
- Biology of Langerhans Cells and Langerhans Cell Histiocytosis2006
- The RAF proteins take centre stageNature Reviews Molecular Cell Biology, 2004
- Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative DiseaseNew England Journal of Medicine, 1994
- Clonal proliferation of Langerhans cells in Langerhans cell histiocytosisThe Lancet, 1994
- SPONTANEOUS REMISSION OF MULTI-SYSTEM HISTIOCYTOSIS XThe Lancet, 1984